Expanded Access and Right To Try Requests: The Community Oncologist's Experience

PURPOSE: For patients with cancer who have exhausted approved treatment options and for whom appropriate clinical trials are not available, access to investigational drugs through the US Food and Drug Administration's Expanded Access (EA) program has been an alternative since the program's...

Descripción completa

Detalles Bibliográficos
Autores principales: Zettler, Marjorie E., Jeune-Smith, Yolaine, Feinberg, Bruce A., Phillips, Ajeet, Gajra, Eli G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
ORIGINAL CONTRIBUTIONS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600511/
https://www.ncbi.nlm.nih.gov/pubmed/33886355
http://dx.doi.org/10.1200/OP.20.00569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600511/
https://www.ncbi.nlm.nih.gov/pubmed/33886355
http://dx.doi.org/10.1200/OP.20.00569

Ejemplares similares